Recent Updates
Recently added Catalysts
MMED Positive Sentiment

MiniMed introduceert Instinct-sensoren in Europa en biedt mensen met diabetes meer keuze met dezelfde bewezen resultaten

Thursday, June 25, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: MiniMed has announced the commercial launch of its MiniMed 780G system integrated with Abbott's Instinct sensor in Europe. This system, along with the MiniMed Go system featuring the Instinct Go sensor, aims to provide enhanced diabetes management options. The rollout of these sensors marks a significant expansion of MiniMed's offerings in the European market.
Price reaction · baseline $14.21 (2026-06-25T13:58:00.000Z) · hit during market hours · 1 other MMED headline(s) in the window, move may be shared
day 0 close · peak
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of MiniMed 780G system integrated with Instinct sensor.
  • Expansion of sensor portfolio in Europe enhances diabetes management.
  • Collaboration with Abbott introduces advanced sensor technology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~21 mo
Low dilution risk
Lead asset
Aventis HOE21PH U400
Phase 3 · Type 1 Diabetes

Full Press Release Details

De geautomatiseerde insulinetoedieningssystemen en slimme systemen voor meerdere dagelijkse injecties van MiniMed kunnen nu worden gecombineerd met Instinct en Instinct Go van Abbott. Dit zijn de kleinste sensoren met de langste draagtijd in het portfolio van het bedrijf.
NORTHRIDGE, Calif.,25 juni 2026/PRNewswire/ -- MiniMed (Nasdaq:MMED), een wereldleider op het gebied van diabetestechnologie, heeft vandaag de commerciële lancering in Europa aangekondigd van het MiniMed™ 780G-systeem geïntegreerd met de Instinct-sensor en het MiniMed Go™-systeem geïntegreerd met de Instinct Go-sensor. De Instinct- en Instinct Go-sensoren, geproduceerd door Abbott, worden vanaf deze maand geleidelijk in Europa uitgerold. Daarmee breidt MiniMed het sensorportfolio in de regio verder uit.

Frequently Asked Questions

What systems did MiniMed launch in Europe?

MiniMed launched the MiniMed 780G system and the MiniMed Go system integrated with Instinct sensors.

Who produces the Instinct sensors?

The Instinct and Instinct Go sensors are produced by Abbott.

What is the significance of the new sensors?

The new sensors enhance diabetes management options and expand MiniMed's portfolio in Europe.

When will the Instinct sensors be available in Europe?

The Instinct sensors will be gradually rolled out in Europe starting this month.

ShareAdd on Google
Tags: MMED Viatris Investor Conferences Healthcare MiniMed Instinct sensors diabetes technology Abbott Europe
Last updated: Jun 25, 2026

Biotech snapshot

Cash runway
$373M liquidity · $16M/mo burn
~21 mo
Low dilution risk
Lead asset
Aventis HOE21PH U400Phase 3
Type 1 Diabetes →